Posted: Tue., Apr. 22, 2008, 8:15am PT

Admissions fall hits Cinemaxx

German exhibitor reports surge in net loss

By ED MEZA

BERLIN — A drop in overall admissions at the box office last year left a dent in the bottom line of Germany’s leading exhib chain Cinemaxx.

The group saw its annual net loss grow by 64% to E5.1 million ($8.1 million) in 2007, while revenue slipped 3.8% to $255.4 million.

Despite an overall 5.7% drop at the German box office and dwindling ad proceeds, Cinemaxx managed to cushion a more drastic decrease in revenue through a 2.8% boost in concession sales and target-group programming, the company said Tuesday.

Operating profit (before interest and tax) reached $7.2 million, down 34% from 2006.

“The film industry, including Cinemaxx, cannot be satisfied with the development of the market in 2007. Despite a high number of high-profile films, the number of admissions remained below expectations,” the company said in a statement.

The local box office picked up dramatically in December and continued to do well through the first quarter of 2008.

Cinemaxx execs are expecting a better performance this year in view of the overall improvement at the box office so far this year and of a slew of upcoming tentpole pics hitting screens in the coming months.


TALKBACK:

Have an opinion about this article? Be the first to comment




Tressa, one of the many stars of A&E's 'Intervention,' talks about her lengthy battle with methamphetamine. ; reality show; intervention; A&E; emmy contenders; drug addicts; variety; Interviews with Erick McCormack, Daniel Dae Kim & Christa Miller, stars of A&E's new sci-fi thriller, 'The Andromeda Strain.'; Erick McCormack; A&E; tv; sci-fi; The Andromeda Strain; variety; Daniel Dae Kim & Christa Miller;


Q What are the top 3 things affecting our industry today?
A. Daena - 1.) The internet 2.) HD Technology 3.) The impending recessionmore >


Submit this form
© 2008 Reed Business Information, a division of Reed Elsevier Inc. All rights reserved. Use of this website is subject to its Terms & Conditions of Use. View our Privacy Policy.